Articles from Eurofins

The PlasticDustCloud project, a global study led by the Eurofins Environment Testing network, has revealed alarming microplastic pollution in air, with deposition rates of up to 1,300 microplastics per square metre per day (/m2/day). Working with samples collected across 12 sites in 9 countries on 3 continents, this global study highlights the pervasive presence of microplastics in the air we breathe every day.

Eurofins Sustainability Services, a full-service provider for retailers, brands, and manufacturers of consumer products, has grown its extensive service offering to include Chem-ST™ for Toys, an advanced chemical smart testing programme designed to help toy manufacturers, brands, and retailers navigate complex global regulations, reduce recall risks, and accelerate product launches. With reliable and sophisticated analytical techniques, this service promotes comprehensive chemical safety in toys.

Eurofins Sustainability Services, a full-service provider for retailers, brands, and manufacturers of consumer products, has grown its extensive service offering to include commodity chemical testing for the softlines industries. With innovative methodology that overcomes the challenges of testing commodity chemicals, this is the first service of its kind to support MRSL compliance of commodity chemicals.

Eurofins Softlines & Hardlines, a full-service testing and certification provider for retailers, brands, importers and manufacturers of consumer products, today announces services to support toy companies with their preparation and transition to the proposed European Toy Safety Regulation (EU TSR). The draft EU TSR introduces stricter safety measures, including tighter chemical restrictions, Digital Product Passport (DPP) requirements and expanded toy categories. Additionally, the proposal includes new visibility requirements for online marketplaces.

Eurofins Environment Testing Eaton Analytical, part of the Eurofins Environment Testing network of laboratories in the US and a leader in water quality analysis, has introduced a cutting-edge method to detect chloronitramide anion, a newly identified disinfection byproduct (DBP), in drinking water. This innovation follows a pivotal study published in Science that identified chloronitramide anion as a previously unidentified decomposition product of chloramine disinfection.

Eurofins Discovery, an industry-leading provider of products and services for drug discovery research, announced today the renewal of its collaboration with Italy-based Dompé farmaceutici S.p.A., which is applying their internal AI platform to accelerate the identification of novel therapeutics.

Eurofins CDMO Alphora Inc., a global Contract Development & Manufacturing Organization and part of the international network of Eurofins laboratories, is pleased to announce a significant expansion of its Drug Product Analytical Services Laboratory, increasing its footprint three-fold. Located in Mississauga, Canada, the expanded facility marks the addition of specialized equipment and analytical techniques, tailored to offer comprehensive analytical support for drug product programs. The laboratory has expanded to encompass water activity measurements, intrinsic dissolution studies, additional glove box systems, an added suite of HPLCs, new stability chambers and gas chromatography.

Eurofins Discovery, an industry-leading provider of products and services for drug discovery research, today announced the launch of DiscoveryAI SAFIRE (Suite of ADMET Predictions For In Silico Refinement and Evaluation). SAFIRE is an advanced platform that leverages proprietary datasets, artificial intelligence (AI), and machine learning (ML), offering a unique capability for expediting discovery. SAFIRE is now available for customer use through the Eurofins Discovery website.

Eurofins MET Labs, part of the global Eurofins (Paris:ERF) network of companies, and a leader in product safety approvals and regulatory certification, is proud to announce the completion of a half-million-dollar expansion of its 10-meter Electromagnetic Compatibility (EMC) Chamber at their Santa Clara laboratory, in collaboration with ETS-Lindgren. This investment significantly enhances the chamber's testing capabilities, enabling manufacturers to meet international EMC compliance regulations.

Eurofins MET Labs, part of the global network of Eurofins (Paris:ERF) laboratories and a global leader in product safety approvals and regulatory certification, has been officially recognized by Intuitive Machines for their crucial contribution to their IM-1 lunar mission. In a significant gesture of acknowledgment, Intuitive Machines has etched the Eurofins MET Labs name onto the lunar lander, symbolizing their lasting contribution to this groundbreaking mission.

Eurofins (Paris:ERF):

Eurofins CDMO Alphora Inc. announces that it has received its Health Canada Cannabis Drug License issued within the Cannabis Act and Cannabis Regulations for its Oakville, Ontario operations in September 2023. This compliments the Institutional Research License obtained through Health Canada in June 2021 for its Mississauga development site and a Standard Processing License obtained for the Oakville, Ontario manufacturing operation in May 2022.

Eurofins CDMO Alphora Inc. is pleased to announce the launch of its Biologics initiative, as part of its vision to diversify and grow within the contract development and manufacturing industry in North America. The multiphase initiative aims to establish a facility at the 2070 Hadwen site within the Sheridan Research Park campus in Mississauga, ON, Canada. The first phase of the project, scheduled for completion by December 2023, is a 3,300 square foot pilot scale facility focused on mammalian cell culture (mAbs) and therapeutic proteins, providing non-cGMP process development and up to 200L scale production.

Eurofins Environment Testing Northern California: Wastewater (EWW) and Eurofins Pandemic Prevention Services (EPPS) today launched a droplet digital PCR (ddPCR) assay for the quantitative analysis of SARS-CoV-2 Variant of Concern (VoC) XBB.1.5 in wastewater.

Eurofins (Paris:ERF):

Eurofins CDMO Alphora Inc. is pleased to announce the relocation and expansion of its API development laboratories from 2395 Speakman Drive to its new, owned facility at 2070 Hadwen Road, located within the Sheridan Research Park in Mississauga, Ontario, Canada.

Eurofins Environment Testing Northern California: Wastewater (EWW) and Eurofins Pandemic Prevention Services (EPPS) today launched a droplet digital PCR (ddPCR) assay for the combined quantitative analysis of SARS-CoV-2 Variants of Concern (VoC) BQ.1 and BQ.1.1 in wastewater. This expansion of EWW and EPPS’ comprehensive SARS-CoV-2 wastewater monitoring platform follows a strategic initiative to continuously monitor novel VoC showing significant incidence within the United States. Omicron subvariants BQ.1 and BQ.1.1 currently comprise >35% of the SARS-CoV-2 virus variant distribution in the US and are increasing at rates that supersede all other current SARS-CoV-2 variants. The World Health Organization has stated that while there is currently no data on severity or immune escape in human studies, BQ.1 shows a significant growth advantage over other circulating Omicron variants and thus warrants monitoring.

Eurofins Sacramento, part of the Eurofins (Paris:ERF) network of companies in the US, in collaboration with SCIEX USA, successfully achieved the analytical challenge of detecting the 2022 interim Health Advisory Levels (HALs) of 4ppq (parts per quadrillion) for PFOA and 20ppq for PFOS, as established by the US EPA.

Eurofins (Paris:ERF):

Eurofins Scientific (EUFI.PA), a global scientific leader in bioanalytical testing, announces that it has successfully signed an agreement with Stichting PAMM Laboratoria voor Pathologie en Medische Microbiologie (“PAMM”), a medical microbiology and pathology laboratory diagnostics company in The Netherlands.

Today, Eurofins (Paris:ERF) subsidiary empowerDX has launched PFAS Exposure™ in the United States, the first direct to consumer at-home test to determine levels of PFAS in a person’s blood and measure 47 of the PFAS “forever chemical” compounds.

Eurofins Technologies (Paris:ERF), a supplier of test kits and systems for laboratory analyses, announces the launch of its new RapidScan ST5-W lateral flow reader, specifically designed for field and in-process testing applications requiring qualitative to semi-quantitative test results.

Per- and Polyfluorinated Alkyl Substances (PFAS), such as PFOA and PFOS, known as “forever chemicals”, characteristically resist natural breakdown in the environment and human bodies. The US Centers for Disease Control and Prevention (CDC) reports that exposure to these chemicals may cause adverse health effects.

Eurofins (Paris:ERF):

Eurofins Scientific, a global leader in food, environment, pharmaceutical and cosmetic product testing, is very pleased to announce that the Steering Committee of the Euronext Indices has made the decision on 9 September 2021 to include Eurofins Scientific in the CAC 40 Index.

Eurofins (Paris:ERF):

Eurofins Technologies (Paris:ERF) announces the launch of its GSD NovaType III SARS-CoV-2 RT-PCR assay, developed for the rapid detection of SARS-CoV-2 Variants of Concern including B.1.617 (“India”), B.1.427/B.1.429 (“California/USA”), B.1.351 (“South Africa”) or P.1 (“Brazil”). The assay facilitates the identification of the relevant mutations E484Q, E484K and L452R in one reaction combined with the simultaneous discrimination from the S gene E484 wildtype variant. These mutations have been associated with reports of potential decreased efficacy of certain vaccines and an increase in the transmissibility of the virus.

Eurofins Technologies continues to develop a range of diagnostic solutions for COVID-19, particularly in response to the threat of emerging mutations. Today, we announce the launch of two new products: GSD NovaPrime® Plus SARS-CoV-2, a PCR test which can detect, in one reaction, key mutations of variants of concern, present for example in the UK variant; and GSD NovaType Select L452R SARS-CoV-2 (RUO) the first test of its type able to detect critical variants such as the Indian, USA and Californian variants. Eurofins Technologies will continue to invest in R&D to develop further reliable, high-quality testing solutions for the SARS-CoV-2 virus and its variants.

Eurofins Covid Testing Services Ltd (ECTS) are now officially an approved government provider for day 2 and day 8 PCR testing. Day 2 and day 8 testing is a mandatory UK government requirement for anyone arriving into the UK from amber and red list countries, with arrivals from green list countries required to take a mandatory test on day 2 only.

Eurofins Covid Testing Services Ltd (ECTS) recognises the importance of testing in the fight against COVID-19. Only the PCR test can provide the accuracy, reliability and variant tracking required to ensure the continued safety of everyone in the UK and whilst travelling.